Emmanuel J Favaloro/LinkedIn
Mar 1, 2026, 09:35
Emmanuel J Favaloro: When Tallied Together, Rare Bleeding Disorders Are Not So Rare
Emmanuel J Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis at Westmead Hospital, Editor in Chief of Seminars in Thrombosis and Hemostasis, shared on LinkedIn:
”28th February is Rare Disease Day.
There are a plethora of rare bleeding disorders, when tallied become not at all rare.
Several rare bleeding disorders, and their management can be found in this issue of Seminars in Thrombosis and Hemostasis.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC